1. Home
  2. ASMB vs VGZ Comparison

ASMB vs VGZ Comparison

Compare ASMB & VGZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASMB
  • VGZ
  • Stock Information
  • Founded
  • ASMB 2005
  • VGZ 1983
  • Country
  • ASMB United States
  • VGZ United States
  • Employees
  • ASMB N/A
  • VGZ N/A
  • Industry
  • ASMB Biotechnology: Pharmaceutical Preparations
  • VGZ
  • Sector
  • ASMB Health Care
  • VGZ
  • Exchange
  • ASMB Nasdaq
  • VGZ Nasdaq
  • Market Cap
  • ASMB 130.2M
  • VGZ 143.6M
  • IPO Year
  • ASMB 2010
  • VGZ N/A
  • Fundamental
  • Price
  • ASMB $17.31
  • VGZ $1.03
  • Analyst Decision
  • ASMB Strong Buy
  • VGZ Strong Buy
  • Analyst Count
  • ASMB 3
  • VGZ 1
  • Target Price
  • ASMB $33.00
  • VGZ $2.75
  • AVG Volume (30 Days)
  • ASMB 32.4K
  • VGZ 941.1K
  • Earning Date
  • ASMB 08-07-2025
  • VGZ 07-28-2025
  • Dividend Yield
  • ASMB N/A
  • VGZ N/A
  • EPS Growth
  • ASMB N/A
  • VGZ N/A
  • EPS
  • ASMB N/A
  • VGZ 0.08
  • Revenue
  • ASMB $32,154,000.00
  • VGZ N/A
  • Revenue This Year
  • ASMB $0.04
  • VGZ N/A
  • Revenue Next Year
  • ASMB N/A
  • VGZ N/A
  • P/E Ratio
  • ASMB N/A
  • VGZ $13.16
  • Revenue Growth
  • ASMB 148.33
  • VGZ N/A
  • 52 Week Low
  • ASMB $7.75
  • VGZ $0.46
  • 52 Week High
  • ASMB $19.93
  • VGZ $1.30
  • Technical
  • Relative Strength Index (RSI)
  • ASMB 68.78
  • VGZ 49.55
  • Support Level
  • ASMB $16.50
  • VGZ $0.96
  • Resistance Level
  • ASMB $17.94
  • VGZ $1.03
  • Average True Range (ATR)
  • ASMB 0.82
  • VGZ 0.04
  • MACD
  • ASMB -0.07
  • VGZ -0.00
  • Stochastic Oscillator
  • ASMB 73.75
  • VGZ 75.00

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About VGZ Vista Gold Corp

Vista Gold Corp is a gold mining company. It is engaged in the evaluation, acquisition, exploration, and advancement of gold exploration and potential development projects. The company evaluate, acquire, explore and advance gold exploration and potential development projects for gold production or value adding strategic transactions. The Company has one reportable segment: Australia. The Australia segment conducts exploration, development, care and maintenance activities at Vista's asset, the Mt Todd gold project in Northern Territory, Australia.

Share on Social Networks: